MX2021014256A - Composiciones alimenticias para mascotas que comprenden acido caprilico y acido docosahexaenoico y/o acido eicosapentaenoico para el uso en el tratamiento de la urolitiasis de estruvita. - Google Patents

Composiciones alimenticias para mascotas que comprenden acido caprilico y acido docosahexaenoico y/o acido eicosapentaenoico para el uso en el tratamiento de la urolitiasis de estruvita.

Info

Publication number
MX2021014256A
MX2021014256A MX2021014256A MX2021014256A MX2021014256A MX 2021014256 A MX2021014256 A MX 2021014256A MX 2021014256 A MX2021014256 A MX 2021014256A MX 2021014256 A MX2021014256 A MX 2021014256A MX 2021014256 A MX2021014256 A MX 2021014256A
Authority
MX
Mexico
Prior art keywords
acid
pet food
food compositions
eicosapetaenoic
docosahexaenoic
Prior art date
Application number
MX2021014256A
Other languages
English (en)
Inventor
Matthew Jackson
Dennis Jewell
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Publication of MX2021014256A publication Critical patent/MX2021014256A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

En la presente descripción se describen composiciones alimenticias para mascotas para tratar o prevenir: -inter alia- urolitiasis de estruvita que comprende al menos uno de ácido caprílico y ácido cáprico; y al menos uno de ácido docosahexaenoico (DHA) y ácido eicosapentaenoico (EPA).
MX2021014256A 2019-05-24 2019-05-24 Composiciones alimenticias para mascotas que comprenden acido caprilico y acido docosahexaenoico y/o acido eicosapentaenoico para el uso en el tratamiento de la urolitiasis de estruvita. MX2021014256A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2019/033899 WO2020242437A1 (en) 2019-05-24 2019-05-24 Pet food compositions comprising caprylic acid and docosahexaenoic acid and/or eicosapetaenoic acid for use in treating struvite urolithiasis

Publications (1)

Publication Number Publication Date
MX2021014256A true MX2021014256A (es) 2022-01-04

Family

ID=67108117

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021014256A MX2021014256A (es) 2019-05-24 2019-05-24 Composiciones alimenticias para mascotas que comprenden acido caprilico y acido docosahexaenoico y/o acido eicosapentaenoico para el uso en el tratamiento de la urolitiasis de estruvita.

Country Status (7)

Country Link
US (1) US20220202759A1 (es)
EP (1) EP3958853A1 (es)
JP (1) JP2022534562A (es)
AU (1) AU2019448583B2 (es)
CA (1) CA3139662A1 (es)
MX (1) MX2021014256A (es)
WO (1) WO2020242437A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102640147B1 (ko) * 2020-11-13 2024-02-26 서성원 배스를 포함하는 반려동물용 사료 조성물 및 이를 이용한 사료 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6538043B2 (ja) * 2013-11-05 2019-07-03 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 腎機能を向上させるための方法及び組成物
JP6639537B2 (ja) * 2018-02-13 2020-02-05 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ネコの水和レベルの向上

Also Published As

Publication number Publication date
AU2019448583A1 (en) 2021-11-18
CA3139662A1 (en) 2020-12-03
US20220202759A1 (en) 2022-06-30
AU2019448583B2 (en) 2023-06-29
JP2022534562A (ja) 2022-08-02
WO2020242437A1 (en) 2020-12-03
EP3958853A1 (en) 2022-03-02

Similar Documents

Publication Publication Date Title
PH12021550756A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
CO6470839A2 (es) Composiciones farmacéuticas que contienen epa y un agente cardiovascular y métodos de emplearlas
MX2017009532A (es) Uso de acidos grasos de cadena corta en prevencion de cancer.
NZ600167A (en) Concentrated therapeutic phospholipid compositions
WO2011097273A8 (en) Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl l-cysteine
WO2006017627A3 (en) Dietary compositions comprising docosahexaenoic acid and eicosapentaenoic acid and use thereof for treating insulin resistance
PH12015501572A1 (en) Veterinary supplements
MX338247B (es) Metodo de tratamiento de enfermedad de almacenamiento de glucogeno o polisacaridos.
CR20160308A (es) Combinaciones de inhibidores de histona deacetilasa y farmacos inmunomoduladores
MX2014004722A (es) Composicion para ser usada en la promocion del crecimiento de hueso sano y/o en la prevencion y/o tratamiento de la enfermedad osea.
BRPI0606766A2 (pt) produtos nutricionais para tratamento dos sintomas da artrite reumatóide
MX350869B (es) Aceleracion de la recuperacion muscular despues de la atrofia muscular inducida por inmovilizacion.
MX2019007771A (es) Composiciones alimenticias para mascotas.
WO2011097276A8 (en) Methods and compositions for treating arthritis with docosahexaenoic acid
EA201791885A1 (ru) Смесь жирных кислот и её применение для лечения воспалительных патологий
GEP201606568B (en) Compositions for the treatment of neurologic disorders
MX354123B (es) Composición antiséptica oral para tratamiento de mucositis oral.
PH12014500859A1 (en) Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
UA88030C2 (ru) Композиция, которая содержит омега-3-жирные кислоты и омега-6-жирные кислоты, для лечения синдрома сухого глаза
EP2560633A4 (en) INTRAVENOUS COMPOSITIONS OF OMEGA-3 FATTY ACIDS AND METHOD OF USE
NZ733322A (en) Grape products for nonalcoholic fatty liver disease and other uses
WO2017077528A3 (en) Methods and pharmaceutical compositions for treatment of lung inflammation
MX2021014256A (es) Composiciones alimenticias para mascotas que comprenden acido caprilico y acido docosahexaenoico y/o acido eicosapentaenoico para el uso en el tratamiento de la urolitiasis de estruvita.
MX2019014888A (es) Composicion nutricional reservada en fosforo.
PH12017500203A1 (en) Nutritional composition for use in promoting gut and/or liver maturation and/or repair